EXAGEN INC. Purchase Agreements

16 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. Five to Asset Purchase Agreement, dated January 26, 2016, by and between Royalty Pharma Collection Trust, Proprius, Inc. and the Registrant
Purchase Agreements
EXAGEN INC.
Health Care Providers & Services
2019
Amendment No. Six to Asset Purchase Agreement, dated February 16, 2017, by and between Royalty Pharma Collection Trust, Proprius, Inc. and the Registrant
Purchase Agreements
EXAGEN INC.
Health Care Providers & Services
2019
Amendment No. Four to Asset Purchase Agreement, dated October 8, 2013, by and between Royalty Pharma Collection Trust, Proprius, Inc. and the Registrant
Purchase Agreements
EXAGEN INC.
Health Care Providers & Services
2019
Amendment No. Three to Asset Purchase Agreement, dated February 6, 2013, by and between Royalty Pharma Collection Trust, Proprius, Inc. and the Registrant
Purchase Agreements
EXAGEN INC.
Health Care Providers & Services
CA
2019
Amendment No. Two to Asset Purchase Agreement, dated August 21, 2012, by and between Royalty Pharma Collection Trust, Proprius, Inc. and the Registrant
Purchase Agreements
EXAGEN INC.
Health Care Providers & Services
CA
2019
Amendment No. One to Asset Purchase Agreement, dated March 10, 2011, by and between Cypress Bioscience, Inc., Proprius, Inc. and the Registrant
Purchase Agreements
EXAGEN INC.
Health Care Providers & Services
2019
Asset Purchase Agreement, dated October 8, 2010, by and between Cypress Bioscience, Inc., Proprius, Inc. and the Registrant
Purchase Agreements
EXAGEN INC.
Health Care Providers & Services
DE
2019
Amendment No. Two to Asset Purchase Agreement, dated January 11, 2017, by and between the Registrant and Cellatope Corporation
Purchase Agreements
EXAGEN INC.
Health Care Providers & Services
2019
Amendment No. One to Asset Purchase Agreement, dated December 14, 2012, by and between the Registrant and Cellatope Corporation
Purchase Agreements
EXAGEN INC.
Health Care Providers & Services
CA
2019
Asset Purchase Agreement, dated February 9, 2009, by and between the Registrant (as successor in interest to Cypress Bioscience, Inc.) and Cellatope Corporation
Purchase Agreements
EXAGEN INC.
Health Care Providers & Services
CA
2019
AMENDMENT NO. FIVE TO ASSET PURCHASE AGREEMENT
Purchase Agreements
EXAGEN INC.
Health Care Providers & Services
2016
AMENDMENT NO. FOUR TO ASSET PURCHASE AGREEMENT AND CONSENT
Purchase Agreements
EXAGEN INC.
Health Care Providers & Services
2016
AMENDMENT NO. ONE TO ASSET PURCHASE AGREEMENT BETWEEN CYPRESS BIOSCIENCE, INC. AND CELLATOPE CORPORATION
Purchase Agreements
EXAGEN INC.
Health Care Providers & Services
CA
2014
AMENDMENT NO. TWO TO ASSETPURCHASE AGREEMENT between: ROYALTY PHARMA COLLECTION TRUST, PROPRIUS, INC. and EXAGEN DIAGNOSTICS, INC. Datedas of August 21, 2012 AMENDMENT NO. TWO TO...
Purchase Agreements
EXAGEN INC.
Health Care Providers & Services
CA
2014
AMENDMENT NO. ONE TO ASSET PURCHASE AGREEMENT BETWEEN CYPRESS BIOSCIENCE, INC. AND CELLATOPE CORPORATION
Purchase Agreements
EXAGEN INC.
Health Care Providers & Services
CA
2014
ASSET PURCHASE AGREEMENT between: CYPRESS BIOSCIENCE, INC., a Delaware corporation and CELLATOPE CORPORATION, a Delaware corporation Dated as ofFebruary 9, 2009 ASSET PURCHASE...
Purchase Agreements
EXAGEN INC.
Health Care Providers & Services
CA
2014